It's a twice-a-year injection that is remarkably effective in preventing an HIV infection. Distribution is starting. But questions are being raised about getting it to the areas that need it most.
An injection of the new drug lenacapavir provides six months of protection against infection by HIV.
Osodi Emmanuel/Reuters
hide caption
toggle caption
Osodi Emmanuel/Reuters
South Africa's launch of Lenacapavir marks a transformative moment in the fight against HIV, promising to significantly reduce…
We look at how lenacapavir, a groundbreaking HIV prevention injection, is set to transform the fight against HIV and why it…
As South Africa becomes the ninth African country to introduce the use of new long-acting drug lenacapavir for HIV prevention,…
Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health…
A twice-yearly injectable HIV prevention drug has arrived in South Africa. The rollout of the drug, lenacapavir, is underway in…
South Africa is rolling out lenacapavir, a twice-yearly injectable drug for HIV prevention that the president calls a turning…
